{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:17:15Z","timestamp":1790255835917,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:00:00Z","timestamp":1775347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"European Union\u2014Next Generation EU\u2014NRRP M6C2\u2014Investment 2.1 Enhancement and strengthening of biomedical research in the NHS"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Introduction. Myotonic dystrophy type 2 (DM2) is an autosomal dominant disorder caused by (CCTG)\n                    <jats:sub>n<\/jats:sub>\n                    repeat expansions in intron 1 of the\n                    <jats:italic>CNBP<\/jats:italic>\n                    gene. Recent evidence from long-read sequencing suggests these expansions may be more complex than previously recognized. Aim. To comprehensively characterize the composition, intergenerational dynamics, and clinical impact of novel (TCTG)\n                    <jats:sub>n<\/jats:sub>\n                    motifs within the\n                    <jats:italic>CNBP<\/jats:italic>\n                    expanded alleles in a large DM2 cohort. Methods. We analyzed 100 genetically confirmed DM2 individuals (45 sporadic, 55 familial). The presence of (TCTG)\n                    <jats:sub>n<\/jats:sub>\n                    blocks was detected using an optimized quadruplet-repeat primed PCR (QP-PCR) assay coupled with Sanger sequencing. In a subset of nine patients, Cas9-mediated enrichment followed by Nanopore Long-Read Sequencing (LRS) provided nucleotide-level resolution of the expanded alleles. Haplotype analysis was performed using STR markers. Results. We identified (TCTG)\n                    <jats:sub>n<\/jats:sub>\n                    blocks at the 3\u2032 end of the expansion in 88% of patients. This refined assay corrected nine initial false-negative diagnoses from standard testing. LRS analysis confirmed the composition and revealed the dynamics of the (TCTG)\n                    <jats:sub>n<\/jats:sub>\n                    tract in familial transmission, showing a tendency for contraction and, in one case, complete loss. Genotype\u2013phenotype correlation analysis indicated that the presence of the (TCTG)\n                    <jats:sub>n<\/jats:sub>\n                    motif acts as a disease modifier, significantly influencing the age of onset. Conclusion. The detailed characterization of the\n                    <jats:italic>CNBP<\/jats:italic>\n                    expansion reveals the novel (TCTG)\n                    <jats:sub>n<\/jats:sub>\n                    component that is integral to the DM2 genotype. Understanding its composition and dynamics enhances diagnostic accuracy and provides a new framework for genetic counselling, prognostic stratification and future personalized therapies. .\n                  <\/jats:p>","DOI":"10.1186\/s40246-026-00954-7","type":"journal-article","created":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T21:25:15Z","timestamp":1775424315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The novel (TCTG)n motif in CNBP expanded alleles: composition, dynamics and genotype\u2013phenotype correlation in Myotonic dystrophy type 2 (DM2)"],"prefix":"10.1186","volume":"20","author":[{"given":"Federica","family":"Centofanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia Veronica","family":"Visconti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"D\u2019Apice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Carlomagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Maestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Ciabini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Bengala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Marchionni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Frezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Massa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Petrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lupidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pegoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Siciliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Garibaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Origone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Delledonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Rossato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Botta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,5]]},"reference":[{"key":"954_CR1","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.3233\/JND-150088","volume":"2","author":"G Meola","year":"2015","unstructured":"Meola G, Cardani R. Myotonic dystrophy type 2: an update on clinical aspects, genetic and pathomolecular mechanism. J Neuromuscul Dis. 2015;2:S59-71. https:\/\/doi.org\/10.3233\/JND-150088.","journal-title":"J Neuromuscul Dis"},{"key":"954_CR2","first-page":"13","volume-title":"Myotonic dystrophies. A genetic overview","author":"P Soltanzadeh","year":"2022","unstructured":"Soltanzadeh P. Myotonic dystrophies. A genetic overview. Genes (Basel): Switzerland; 2022. p. 13 10.3390\/genes13020367."},{"key":"954_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-019-0924-0","volume":"19","author":"A Romigi","year":"2019","unstructured":"Romigi A, Maestri M, Nicoletta C, Vitrani G, Caccamo M, Siciliano G, et al. Sleep complaints, sleep and breathing disorders in myotonic dystrophy type 2. Curr Neurol Neurosci Rep. 2019;19:9. https:\/\/doi.org\/10.1007\/s11910-019-0924-0.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"954_CR4","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1007\/s00415-017-8653-2","volume":"264","author":"F Montagnese","year":"2017","unstructured":"Montagnese F, Mondello S, Wenninger S, Kress W, Schoser B. Assessing the influence of age and gender on the phenotype of myotonic dystrophy type 2. J Neurol. 2017;264:2472\u201380. https:\/\/doi.org\/10.1007\/s00415-017-8653-2.","journal-title":"J Neurol"},{"key":"954_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.nmd.2013.02.013","volume":"23","author":"J Radvanszky","year":"2013","unstructured":"Radvanszky J, Surovy M, Polak E, Kadasi L. Uninterrupted CCTG tracts in the myotonic dystrophy type 2 associated locus. Neuromuscul Disord. 2013;23:591\u20138. https:\/\/doi.org\/10.1016\/j.nmd.2013.02.013.","journal-title":"Neuromuscul Disord"},{"key":"954_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00463","volume":"9","author":"AS Mahyera","year":"2018","unstructured":"Mahyera AS, Schneider T, Halliger-Keller B, Schrooten K, H\u00f6rner E-M, Rost S, et al. Distribution and structure of DM2 repeat tract alleles in the German population. Front Neurol. 2018;9:463. https:\/\/doi.org\/10.3389\/fneur.2018.00463.","journal-title":"Front Neurol"},{"key":"954_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1515\/bmc-2016-0024","volume":"7","author":"P Guo","year":"2016","unstructured":"Guo P, Lam SL. Unusual structures of CCTG repeats and their participation in repeat expansion. Biomol Concepts Ger. 2016;7:331\u201340. https:\/\/doi.org\/10.1515\/bmc-2016-0024.","journal-title":"Biomol Concepts Ger"},{"key":"954_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.668094","author":"A Botta","year":"2021","unstructured":"Botta A, Visconti VV, Fontana L, Bisceglia P, Bengala M, Massa R, et al. A 14-Year Italian experience in DM2 genetic testing: frequency and distribution of normal and premutated CNBP alleles. Front Genet Front Med SA. 2021. https:\/\/doi.org\/10.3389\/fgene.2021.668094.","journal-title":"Front Genet Front Med SA"},{"key":"954_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2025.115793","volume":"700","author":"I Lojova","year":"2025","unstructured":"Lojova I, Kucharik M, Zatkova A, Balaz A, P\u00f6s Z, Tarova ET, et al. High-resolution repeat structure analysis in myotonic dystrophy type 2 diagnostics using short-read whole genome sequencing. Anal Biochem. 2025;700:115793. https:\/\/doi.org\/10.1016\/j.ab.2025.115793.","journal-title":"Anal Biochem"},{"key":"954_CR10","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.ajhg.2021.03.011","volume":"108","author":"C Depienne","year":"2021","unstructured":"Depienne C, Mandel J-L. 30 years of repeat expansion disorders: what have we learned and what are the remaining challenges? Am J Hum Genet. 2021;108:764\u201385. https:\/\/doi.org\/10.1016\/j.ajhg.2021.03.011.","journal-title":"Am J Hum Genet"},{"key":"954_CR11","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1126\/science.1062125","volume":"293","author":"CL Liquori","year":"2001","unstructured":"Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science. 2001;293:864\u20137. https:\/\/doi.org\/10.1126\/science.1062125.","journal-title":"Science"},{"key":"954_CR12","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/EJHG.2012.108","volume":"20","author":"EJ Kamsteeg","year":"2012","unstructured":"Kamsteeg EJ, Kress W, Catalli C, Hertz JM, Witsch-Baumgartner M, Buckley MF, et al. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. Eur J Hum Genet. 2012;20:1203\u20138. https:\/\/doi.org\/10.1038\/EJHG.2012.108.","journal-title":"Eur J Hum Genet"},{"key":"954_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2014.04.011","author":"CA Thornton","year":"2014","unstructured":"Thornton CA. Myotonic dystrophy. Neurol Clin. 2014. https:\/\/doi.org\/10.1016\/j.ncl.2014.04.011.","journal-title":"Neurol Clin"},{"key":"954_CR14","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1007\/s00415-012-6462-1","volume":"259","author":"R Cardani","year":"2012","unstructured":"Cardani R, Giagnacovo M, Botta A, Rinaldi F, Morgante A, Udd B, et al. Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2. J Neurol Ger. 2012;259:2090\u20139. https:\/\/doi.org\/10.1007\/s00415-012-6462-1.","journal-title":"J Neurol Ger"},{"key":"954_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.nmd.2015.01.006","volume":"25","author":"E Bugiardini","year":"2015","unstructured":"Bugiardini E, Rivolta I, Binda A, Soriano Caminero A, Cirillo F, Cinti A, et al. SCN4A mutation as modifying factor of myotonic dystrophy type 2 phenotype. Neuromuscul Disord. 2015;25:301\u20137. https:\/\/doi.org\/10.1016\/j.nmd.2015.01.006.","journal-title":"Neuromuscul Disord"},{"key":"954_CR16","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s10072-024-07826-9","volume":"46","author":"M Rimoldi","year":"2025","unstructured":"Rimoldi M, Lucchiari S, Pagliarani S, Meola G, Comi GP, Abati E. Myotonic dystrophies: an update on clinical features, molecular mechanisms, management, and gene therapy. Neurol Sci. 2025;46:1599\u2013616. https:\/\/doi.org\/10.1007\/s10072-024-07826-9.","journal-title":"Neurol Sci"},{"key":"954_CR17","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S1474-4422(12)70204-1","volume":"11","author":"B Udd","year":"2012","unstructured":"Udd B, Krahe R. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol. 2012;11:891\u2013905. https:\/\/doi.org\/10.1016\/S1474-4422(12)70204-1.","journal-title":"Lancet Neurol"},{"key":"954_CR18","first-page":"23","volume":"25","author":"A Botta","year":"2006","unstructured":"Botta A, Bonifazi E, Vallo L, Gennarelli M, Garr\u00e8 C, Salehi L, et al. Italian guidelines for molecular analysis in myotonic dystrophies. Acta Myol Myopath Cardiomyopath. 2006;25:23\u201333.","journal-title":"Acta Myol Myopath Cardiomyopath"},{"key":"954_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae1155","author":"S Maestri","year":"2025","unstructured":"Maestri S, Scalzo D, Damaggio G, Zobel M, Besusso D, Cattaneo E. Navigating triplet repeats sequencing: concepts, methodological challenges and perspective for Huntington\u2019s disease. Nucleic Acids Res Engl. 2025. https:\/\/doi.org\/10.1093\/nar\/gkae1155.","journal-title":"Nucleic Acids Res Engl"},{"key":"954_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2025.1610026","volume":"16","author":"M Chaushevska","year":"2025","unstructured":"Chaushevska M, Alapont-Celaya K, Schack AK, Krych L, Garrido Navas MC, Krithara A, et al. Get ready for short tandem repeats analysis using long reads-the challenges and the state of the art. Front Genet. 2025;16:1610026. https:\/\/doi.org\/10.3389\/fgene.2025.1610026.","journal-title":"Front Genet"},{"key":"954_CR21","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.80229","author":"M Alfano","year":"2022","unstructured":"Alfano M, De Antoni L, Centofanti F, Visconti VV, Maestri S, Degli Esposti C, et al. Characterization of full-length CNBP expanded alleles in myotonic dystrophy type 2 patients by Cas9-mediated enrichment and nanopore sequencing. Elife Engl. 2022. https:\/\/doi.org\/10.7554\/eLife.80229.","journal-title":"Elife Engl"},{"key":"954_CR22","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3233\/JND-210671","volume":"8","author":"M Damen","year":"2021","unstructured":"Damen M, Schijvenaars M, Schimmel-Naber M, Groothuismink J, Coenen M, Tieleman A. Ancestral origin of the first indian families with myotonic dystrophy type 2. J Neuromuscul Dis. 2021;8:715\u201322. https:\/\/doi.org\/10.3233\/JND-210671.","journal-title":"J Neuromuscul Dis"},{"key":"954_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/ejhg.2010.233","volume":"19","author":"MJH Coenen","year":"2011","unstructured":"Coenen MJH, Tieleman AA, Schijvenaars MMVAP, Leferink M, Ranum LPW, Scheffer H, et al. Dutch myotonic dystrophy type 2 patients and a North-African DM2 family carry the common European founder haplotype. Eur J Hum Genet Engl. 2011;19:567\u201370. https:\/\/doi.org\/10.1038\/ejhg.2010.233.","journal-title":"Eur J Hum Genet Engl"},{"key":"954_CR24","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1086\/378720","volume":"73","author":"CL Liquori","year":"2003","unstructured":"Liquori CL, Ikeda Y, Weatherspoon M, Ricker K, Schoser BGH, Dalton JC, et al. Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract. Am J Hum Genet. 2003;73:849\u201362. https:\/\/doi.org\/10.1086\/378720.","journal-title":"Am J Hum Genet"},{"key":"954_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10048-007-0110-4","volume":"9","author":"T Saito","year":"2008","unstructured":"Saito T, Amakusa Y, Kimura T, Yahara O, Aizawa H, Ikeda Y, et al. Myotonic dystrophy type 2 in Japan: ancestral origin distinct from Caucasian families. Neurogenetics. 2008;9:61\u20133. https:\/\/doi.org\/10.1007\/s10048-007-0110-4.","journal-title":"Neurogenetics"},{"key":"954_CR26","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1086\/378566","volume":"73","author":"LL Bachinski","year":"2003","unstructured":"Bachinski LL, Udd B, Meola G, Sansone V, Bassez G, Eymard B, et al. Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy\/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect. Am J Hum Genet. 2003;73:835\u201348. https:\/\/doi.org\/10.1086\/378566.","journal-title":"Am J Hum Genet"},{"key":"954_CR27","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsd\u00f3ttir","year":"2013","unstructured":"Thorvaldsd\u00f3ttir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform Engl. 2013;14:178\u201392. https:\/\/doi.org\/10.1093\/bib\/bbs017.","journal-title":"Brief Bioinform Engl"},{"key":"954_CR28","doi-asserted-by":"publisher","first-page":"e200220","DOI":"10.1212\/NXG.0000000000200220","volume":"11","author":"M Wendlandt","year":"2025","unstructured":"Wendlandt M, Erdmann H, Rost S, Lucas MC, Becker K, Kleinle S, et al. Updated structure of CNBP repeat expansions in patients with myotonic dystrophy type 2 and its implication for standard diagnostics. Neurol Genet. 2025;11:e200220. https:\/\/doi.org\/10.1212\/NXG.0000000000200220.","journal-title":"Neurol Genet"},{"key":"954_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/cge.12954","volume":"92","author":"M Santoro","year":"2017","unstructured":"Santoro M, Masciullo M, Silvestri G, Novelli G, Botta A. Myotonic dystrophy type 1: role of CCG, CTC and CGG interruptions within DMPK alleles in the pathogenesis and molecular diagnosis. Clin Genet. 2017;92:355\u201364. https:\/\/doi.org\/10.1111\/cge.12954.","journal-title":"Clin Genet"},{"key":"954_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1089\/gtmb.2010.0127","volume":"15","author":"J Radvansky","year":"2011","unstructured":"Radvansky J, Ficek A, Kadasi L. Repeat-primed polymerase chain reaction in myotonic dystrophy type 2 testing. Genet Test Mol Biomarkers. 2011;15:133\u20136. https:\/\/doi.org\/10.1089\/gtmb.2010.0127.","journal-title":"Genet Test Mol Biomarkers"},{"key":"954_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210129","author":"VV Visconti","year":"2023","unstructured":"Visconti VV, Macr\u00ec E, D\u2019Apice MR, Centofanti F, Massa R, Novelli G, et al. In cis effect of DMPK expanded alleles in myotonic dystrophy type 1 patients carrying variant repeats at 5\u2032 and 3\u2032 ends of the CTG array. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241210129.","journal-title":"Int J Mol Sci"},{"key":"954_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/genes13060970","author":"A Rasmussen","year":"2022","unstructured":"Rasmussen A, Hildonen M, Vissing J, Duno M, T\u00fcmer Z, Birkedal U. High resolution analysis of DMPK hypermethylation and repeat interruptions in myotonic dystrophy type 1. Genes (Basel). 2022. https:\/\/doi.org\/10.3390\/genes13060970.","journal-title":"Genes (Basel)"},{"key":"954_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/gpbjnl\/qzaf094","author":"L Benarroch","year":"2025","unstructured":"Benarroch L, Bo\u00eblle P-Y, Madry H, Mohand Oumoussa B, Eura N, Nishino I, et al. Comparative analysis of CRISPR\/Cas9-targeted nanopore sequencing approaches in repeat expansion disorders. Genomics Proteom Bioinf. 2025. https:\/\/doi.org\/10.1093\/gpbjnl\/qzaf094.","journal-title":"Genomics Proteom Bioinf"},{"key":"954_CR34","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1212\/01.WNL.0000054481.84978.F9","volume":"60","author":"JW Day","year":"2003","unstructured":"Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W, et al. Myotonic dystrophy type 2: Molecular, diagnostic and clinical spectrum. Neurology. 2003;60:657\u201364. https:\/\/doi.org\/10.1212\/01.WNL.0000054481.84978.F9.","journal-title":"Neurology"},{"key":"954_CR35","doi-asserted-by":"publisher","first-page":"e995","DOI":"10.1212\/WNL.0000000000008056","volume":"93","author":"SA Cumming","year":"2019","unstructured":"Cumming SA, Jimenez-Moreno C, Okkersen K, Wenninger S, Daidj F, Hogarth F, et al. Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort. Neurology. 2019;93:e995-1009. https:\/\/doi.org\/10.1212\/WNL.0000000000008056.","journal-title":"Neurology"},{"key":"954_CR36","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41580-021-00382-6","volume":"22","author":"I Malik","year":"2021","unstructured":"Malik I, Kelley CP, Wang ET, Todd PK. Molecular mechanisms underlying nucleotide repeat expansion disorders. Nat Rev Mol Cell Biol Engl. 2021;22:589\u2013607. https:\/\/doi.org\/10.1038\/s41580-021-00382-6.","journal-title":"Nat Rev Mol Cell Biol Engl"},{"key":"954_CR37","doi-asserted-by":"publisher","first-page":"7185","DOI":"10.1007\/s12035-023-03531-4","volume":"60","author":"Y Wu","year":"2023","unstructured":"Wu Y, Song T, Xu Q. R-LOOPs on short tandem repeat expansion disorders in neurodegenerative diseases. Mol Neurobiol. 2023;60:7185\u201395. https:\/\/doi.org\/10.1007\/s12035-023-03531-4.","journal-title":"Mol Neurobiol"},{"key":"954_CR38","doi-asserted-by":"publisher","first-page":"E8392","DOI":"10.1073\/pnas.1711283114","volume":"114","author":"XA Su","year":"2017","unstructured":"Su XA, Freudenreich CH. Cytosine deamination and base excision repair cause R-loop-induced CAG repeat fragility and instability in Saccharomyces cerevisiae. Proc Natl Acad Sci USA. 2017;114:E8392-401. https:\/\/doi.org\/10.1073\/pnas.1711283114.","journal-title":"Proc Natl Acad Sci USA"},{"key":"954_CR39","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00294-018-0806-z","volume":"64","author":"CH Freudenreich","year":"2018","unstructured":"Freudenreich CH. R-loops: targets for nuclease cleavage and repeat instability. Curr Genet. 2018;64:789\u201394. https:\/\/doi.org\/10.1007\/s00294-018-0806-z.","journal-title":"Curr Genet"},{"key":"954_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/g3journal\/jkad257","author":"D Papp","year":"2024","unstructured":"Papp D, Hernandez LA, Mai TA, Haanen TJ, O\u2019Donnell MA, Duran AT, et al. Massive contractions of myotonic dystrophy type 2-associated CCTG tetranucleotide repeats occur via double-strand break repair with distinct requirements for DNA helicases. G3 (Bethesda). 2024. https:\/\/doi.org\/10.1093\/g3journal\/jkad257.","journal-title":"G3 (Bethesda)"},{"key":"954_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02102-5","volume":"23","author":"H Zhou","year":"2025","unstructured":"Zhou H, Xu J, Pan L. Functions of the muscleblind-like protein family and their role in disease. Cell Commun Signal. 2025;23:97. https:\/\/doi.org\/10.1186\/s12964-025-02102-5.","journal-title":"Cell Commun Signal"},{"key":"954_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04370-x","volume":"9","author":"C Sellier","year":"2018","unstructured":"Sellier C, Cerro-Herreros E, Blatter M, Freyermuth F, Gaucherot A, Ruffenach F, et al. Rbfox1\/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1\/type 2 differences. Nat Commun. 2018;9:2009. https:\/\/doi.org\/10.1038\/s41467-018-04370-x.","journal-title":"Nat Commun"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-026-00954-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-026-00954-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-026-00954-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:29:35Z","timestamp":1781645375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40246-026-00954-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,5]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["954"],"URL":"https:\/\/doi.org\/10.1186\/s40246-026-00954-7","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,5]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board of Policlinico Tor Vergata (Ethical Approval register numbers: 61\/23), and all procedures were performed in accordance with the Declaration of Helsinki. Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}